Avnet: Stable, But Still A Hold Until Q4 Earnings Are In

Avnet Inc. (AVT) reported Q3 2025 revenue of $5.32 billion, a 6% year-over-year decline, and a 25% drop in operating income, yet significantly outperformed EPS guidance at $0.84. While demand remained sluggish in the Americas and EMEA, Asia emerged as a key growth driver, up 13%, signaling a regional recovery divergence. The company continues to manage persistent inventory and soft OEM demand, though improving book-to-bill ratios suggest stabilizing conditions. With Q4 guidance largely flat and a discounted valuation reflecting ongoing cyclical headwinds, AVT is seen as a near-term "Hold" due to steady execution amid a slow recovery.

Analysis

Avnet, Inc. reported a resilient but challenging Q3 2025, with revenue declining 6% year-over-year to $5.32 billion, driven by significant demand weakness in the Americas (-9%) and EMEA (-24%). This downturn was partially offset by a notable 13% sales growth in Asia, highlighting a significant regional divergence in market recovery. Despite a 25% drop in operating income, the company demonstrated strong operational control by delivering an EPS of $0.84, which surpassed the midpoint of its guidance by 20%. Key indicators suggest a bottoming process is underway, as book-to-bill ratios are approaching parity across all regions, signaling demand stabilization. Management's Q4 guidance for revenue of $5.15-$5.45 billion and EPS of $0.65-$0.75 indicates a flat sequential outlook, reinforcing the expectation of a slow recovery. While inventory levels remain elevated in certain areas, the company is generating strong cash flow from operations ($141 million) and returning over $100 million to shareholders via buybacks and dividends. The stock's valuation, with an EV/EBITDA of ~10x and an EV/Revenue of 0.33x, reflects a discount to peers, pricing in cyclical headwinds without a clear near-term catalyst for re-rating.

Key Decisions for Investors

• Investors should monitor book-to-bill ratios in the Americas and EMEA, as a sustained move to parity or higher would be the primary catalyst signaling a broad-based demand recovery.
• Given the discounted valuation relative to peers but lack of immediate growth drivers, a neutral or 'Hold' position is warranted until Q4 results provide evidence of margin stability and sustained demand improvements.
• Pay close attention to continued strength in the Asian segment, as its performance is critical for offsetting ongoing weakness in Western markets and validating the recovery narrative.
• Consider the geopolitical risk associated with tariffs, as 7-10% of Americas sales are sourced from China, which could introduce margin pressure if trade tensions escalate.